Inventor · disambiguated record
Michael M. Wick
Also filed as: WICK MICHAEL · WICK MICHAEL M
11 granted patents·3 pending applications·501 citations·filing 1994–2012
93Inventor score
Top patents by PatentIndex Score
14 records- 0194US5866702APurine inhibitors of cyclin dependent kinase 2CV THERAPEUTICS INC·Filed 1996·Granted Feb 2, 1999·142 cites·6 claims
- 0293US6794390B2Purine inhibitors of cyclin dependent kinase 2 & ikappabalphaCV THERAPEUTICS INC·Filed 2001·Granted Sep 21, 2004·43 cites·11 claims
- 0391US6075150Aα-ketoamide inhibitors of 20S proteasomeCV THERAPEUTICS INC·Filed 1998·Granted Jun 13, 2000·96 cites·2 claims
- 0491US5789416AN6 mono heterocyclic substituted adenosine derivativesCV THERAPEUTICS INC·Filed 1996·Granted Aug 4, 1998·107 cites·14 claims
- 0582US6781000B1Alpha-ketoamide inhibitors of 20S proteasomeCV THERAPEUTICS INC·Filed 1999·Granted Aug 24, 2004·50 cites·14 claims
- 0670US5834487AInhibition of 26S and 20S proteasome by indanonesCV THERAPEUTICS·Filed 1996·Granted Nov 10, 1998·27 cites·11 claims
- 0766US8207121B2Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compoundBROWN GAIL L·Filed 2007·Granted Jun 26, 2012·1 cites·2 claims
- 0859US6790958B2Purine inhibitors of cyclin dependent kinase 2 & IKBAFiled 2001·Granted Sep 14, 2004·16 cites·3 claims
- 0952US7109330B2Purine inhibitors of cyclin dependent kinase 2 and IκB-αCV THERAPEUTICS INC·Filed 2004·Granted Sep 19, 2006·6 cites·3 claims
- 1052US2005261202A1Sensitization to another anticancer therapy and/or amelioration of a side effect of another anitcancer therapy by treatment with a GST-activated anticancer compoundBROWN GAIL L·Filed 2005·Application pending·0 cites
- 1151US6117887AInhibition of 26S and 20S proteasome by indanonesCV THERAPEUTICS INC·Filed 1998·Granted Sep 12, 2000·8 cites·9 claims
- 1245US2012251496A1Ezatiostat for treating multiple myelomaWICK MICHAEL M·Filed 2012·Application pending·0 cites
- 1344US5593671AMethod of attenuating lung capillary leak in a mammalAMERICAN CYANAMID CO·Filed 1994·Granted Jan 14, 1997·5 cites·9 claims
- 1433US2015182525A14-Amino-5-Fluoro-3-[6-(4-Methylpiperazin-1-YL)-1H-Benzimidazol-2-YL]-1H-Quinolin-2-one for use in the Treatment of Adenoid Cystic CarcinomaSHI MICHAEL·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael M. Wick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →